As vaccine makers start testing re-tooled versions to target variants, how long will immunity hold up? And as vaccines open to all adults, some are still waiting. Why?
The site was producing substances for both the Johnson & Johnson and AstraZeneca vaccines. But following a mix-up, the facility will focus solely on producing ingredients for the J&J vaccine.
Over 100 million Americans have received at least one dose of a COVID-19 vaccine. That number is climbing by about 3 million daily. We hear the latest information on how well the vaccines are working.
During Sunday's ceremony, the pope had harsh words for armed forces, support for struggling countries, and urged the use of vaccinations to curb the pandemic.
NPR's Lulu Garcia-Navarro speaks with an infectious disease expert in Chile, Dr. Claudia Cortes, about a new wave of COVID-19 infections, despite the country's rapid vaccination pace.
NPR's Lulu Garcia-Navarro speaks with New York Times fashion director Vanessa Friedman about the selfie photographs that people post on social media after receiving their COVID-19 vaccine.
As vaccines fan out across the U.S., why can some people get a shot and others can't? NPR's Scott Simon speaks with Dr. Rebecca Weintraub of Harvard Medical School about bottlenecks.
At an animal sanctuary in the Congo, young students are learning why the gentle, endangered apes known as bonobos should be seen as a national treasure.